Gencyte Therapeutics
Business Services · 1-10 Employees
View Company Info for Free
Overview
Phone Number
(408) 340-8606Website
www.gencytetherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Gencyte Therapeutics
Gencyte Therapeutics is dedicated to developing next-generation Chimeric Antigen Receptor T-cell (CAR-T) immunotherapy aimed at precision cancer treatment. Their innovative approach seeks to enhance the precision targeting of CAR-T while addressing its limitations, such as high toxicity and ineffectiveness against solid tumors. The company aims to create therapies that are less toxic and can treat a broader range of cancers, thereby expanding treatment options for more cancer patients. Gencyte Therapeutics is positioned to meet the unmet medical needs in the field of cancer therapy.Explore more
Popular SearchesGencyte TherapeuticsGencyte Therapeutics SanGencyte Therapeutics isSIC Code 87,873NAICS Code 54,541Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Gencyte Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Gencyte Therapeutics
Funding: Get notified immidiatlly once Gencyte Therapeutics has new funding data
Check if Gencyte Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Gencyte Therapeutics is spiking on competitors!
Product Launch: Get notified when Gencyte Therapeutics launches new products
Gencyte Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Gencyte Therapeutics recently announced quarterly report
Click to see if Gencyte Therapeutics had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Gencyte Therapeutics
Compare insights from companies similar to Gencyte Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Gencyte Therapeutics
<$5M
1-10
Private
-
-
N/A
Company Profile Activity
Activity Insights
Gencyte Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Gencyte Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Gencyte Therapeutics.
Gencyte Therapeutics Tech Stack
A closer look at the technologies used by Gencyte Therapeutics
See more technologies
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Gencyte Therapeutics
Sign Up For FreeTo access detailed company insights
Gencyte Therapeutics is dedicated to developing next-generation Chimeric Antigen Receptor T-cell (CAR-T) immunotherapy aimed at precision cancer treatment. Their innovative approach seeks to enhance the precision targeting of CAR-T while addressing its limitations, such as high toxicity and ineffectiveness against solid tumors. The company aims to... Read More
